New treatment using GOLD boosts results of chemotherapy in pancreatic cancer:
GOLD nanoparticles could potentially supplement chemotherapy treatment for cancer patients, a new study suggests.
Experiments involving pancreatic cancer cells and pancreatic stellate cells in a mouse model showed that tiny gold particles can be used as a vehicle to carry chemotherapy drug molecules into tumours.
They can also be used as a target to enhance radiation treatment on tumours.
The gold nanoparticles were able to disrupt cellular communication in the area surrounding the tumors without harming normal cells.
The results were published in ACS NANO, a journal of the American Chemical Society.
In the United States alone, 42,000 people are expected to die of the disease in 2016.
The National Institute for Health and Care Excellence (NICE) has recommended the drug nivolumab to be made available to late-stage kidney cancer patients through the NHS, in a bid to extend the lives of thousands of kidney cancer patients who may have faced an early death.
Kidney cancer patients across England, Wales and Northern Ireland told Kidney Cancer UK they were optimistic of good news in light of the excellent scientific data surrounding nivolumab, and the recommendation has been welcomed by patients.
*credit verbatim via http://www.express.co.uk and Lauren O’Callaghan*